NEWS & INSIGHTS

Latest News
Exscientia appoints Richard Law to expand its AI-drug discovery partnering business
Read Now

All

Exscientia appoints Richard Law to expand its AI-drug discovery partnering business

READ MORE

Exscientia launches Miami Office to recruit US-based Technology talent as part of continued expansion.

READ MORE

Exscientia applies Genome scale AI-Drug Discovery to critical global health challenges - Company receives $4.2M grant from Bill & Melinda Gates Foundation to identify new targets and leads for malaria, tuberculosis, and non-hormonal contraception

READ MORE

Exscientia appoints biopharma investment banker and executive Ben Taylor as Chief Financial Officer

READ MORE

Exscientia recruits industry innovator Garry Pairaudeau as Chief Technology Officer

READ MORE

Exscientia and Blue Oak Pharmaceuticals announce collaboration to rapidly discover innovative treatments for CNS disorders

READ MORE

Exscientia appoints industry R&D veteran, David Nicholson, as Chairman as company extends pipeline

READ MORE

Huadong Medicine and Exscientia enter co-development partnership to accelerate oncology drug discovery through artificial intelligence

READ MORE

Exscientia Featured in TECH TRACK 100 report on Britain's Fastest Growing Tech Companies

READ MORE
  • <<
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • >>